As for GLP-1 agonists, there is a potential risk of pancreatitis, while DPP-4 inhibitors can increase susceptibility to conditions like nasopharyngitis and upper respiratory infections.
Methods A structured literature search was conducted using online databases to identify relevant studies published over the past two decades
doi: 10.1038/s41467-020-15109-y 100 ChenHLiuSJiLWuTJiYZhouYet al
The ideal trial duration clearly depends on the expected mechanism of the treatment to be studied and relies heavily on the primary outcome measure chosen
However, you might suspect an MTHFR mutation if you: Have a family history of heart disease, stroke, or blood clots Experience multiple unexplained symptoms across different body systems Have elevated homocysteine or low B12/folate levels on blood tests Struggled with infertility, miscarriages, or pregnancy complications Dont respond well to standard treatments for anxiety or depression Have chronic health issues that improve with methylated B vitamins The most definitive way to know is through genetic testing (blood test or saliva test) that identifies MTHFR variants like C677T or A1298C
Rybelsus has now demonstrated proven cardiovascular risk reduction in the landmark SOUL trial (McGuire et al., NEJM 2025)